Published online Nov 26, 2021. doi: 10.4252/wjsc.v13.i11.1762
Peer-review started: May 1, 2021
First decision: June 16, 2021
Revised: June 28, 2021
Accepted: September 2, 2021
Article in press: September 2, 2021
Published online: November 26, 2021
Processing time: 207 Days and 22.1 Hours
Acute muscle injuries are one of the most common injuries in sports. Severely injured muscles are prone to re-injury due to fibrotic scar formation caused by prolonged inflammation. How to regulate inflammation and suppress fibrosis is the focus of promoting muscle healing. Recent studies have found that myoblasts and macrophages play important roles in the inflammatory phase following muscle injury; however, the crosstalk between these two types of cells in the inflammatory environment, particularly the exosome-related mechanisms, had not been well studied.
To evaluate the effects of exosomes from inflammatory C2C12 myoblasts (IF-C2C12-Exos) on macrophage polarization and myoblast proliferation/differentiation.
A model of inflammation was established in vitro by lipopolysaccharide stimu
We found that the PKH-67-marked C2C12-Exos can be endocytosed by both macrophages and myoblasts. IF-C2C12-Exos induced M1 macrophage polariz
IF-C2C12-Exos can induce M1 polarization, resulting in a sustained and aggr
Core Tip: For successful muscle regeneration, macrophage polarization and myogenesis should be supported by an appropriate combination of cells and their signals. As the communication between myoblasts and macrophages within the inflammatory environment is unknown, we aimed to evaluate the effects of IF-C2C12-Exos on macrophage polarization and myoblast proliferation/differentiation. We found that IF-C2C12-Exos could induce M1 polarization, resulting in a sustained and exacerbated inflammatory environment, impaired myoblast fibrogenic/myogenic differentiation, and led to abnormal myogenic proliferation. These results indicate a potential mechanism for the development of long-term inflammation following acute muscle injury, but further preclinical evaluations targeting IF-C2C12-Exos in animal models are necessary.